Newswire (Published: Tuesday, March 7, 2017, Received: Thursday, March 2, 2017, 9:09:24 PM CST)

Word Count: 385

New Prostate Cancer Findings from N.H.J. Bittner and Co-Researchers Described (The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer)

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating from Tacoma, Washington, by NewsRx correspondents, research stated, "Transperineal permanent brachytherapy is a safe and effective treatment option for patients with organ-confined prostate cancer. Careful adherence to established brachytherapy standards has been shown to improve the likelihood of procedural success and reduce the incidence of treatment related morbidity."

Our news editors obtained a quote from the research, "A collaborative effort of the American College of Radiology (ACR) and the American Brachytherapy Society (ABS) has produced practice parameters for LDR prostate brachytherapy. These practice parameters define the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist and dosimetrist. Factors with respect to patient selection and appropriate use of supplemental treatment modalities such as external beam radiation and androgen suppression therapy are discussed. Logistics with respect to the brachytherapy implant procedure, the importance of dosimetric guidelines, and attention to radiation safety procedures and documentation are presented."

According to the news editors, the research concluded: "Adherence to these parameters can be part of ensuring quality and safety in a successful prostate brachytherapy program."

For more information on this research see: The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer. Brachytherapy, 2017;16(1):59-67. Brachytherapy can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA. (Elsevier - www.elsevier.com; Brachytherapy - www.journals.elsevier.com/brachytherapy/)

The news editors report that additional information may be obtained by contacting N.H.J. Bittner, Tacoma Valley Radiat Oncol Center, Tacoma, WA, United States. Additional authors for this research include P.F. Orio, G.S. Merrick, B.R. Prestidge, A.C. Hartford and S.A. Rosenthal (see also Oncology - Prostate Cancer).

Keywords for this news article include: Tacoma, Washington, United States, North and Central America, Drugs and Therapies, Prostatic Neoplasms, Prostate Cancer, Brachytherapy, Radiotherapy, Radiology, Oncology, Therapy.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

American College of Radiology Inc

Places

Central America
North America
United States
Americas
New York
Washington
New York City
Tacoma

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Medical Specialties and Practices
            Radiology